Biosino Bio-Technology and Science Incorporation (SEHK: 8247)
Health Care · Biotechnology · CN
HK$3.22
+0.47% today · +228.6% 1Y
Biosino Bio-Technology and Science Incorporation (SEHK: 8247) operates in the Biotechnology industry within the Health Care sector. The company is valued at $59.43M and employs 450 people.
Over the last twelve months the share price has gained 228.6%, trading between 0.60 and 7.00.
Tweenvest scores Biosino Bio-Technology and Science Incorporation across four factors: quality 51/100, value 60/100, growth 0/100. Its strongest factor is value.
8247 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $59.43M
- Revenue (TTM)
- $25.12M
- P/E
- —
- EPS
- -0.30
- Dividend yield
- —
- Beta (5Y)
- 0.48
- 52-week high
- HK$7.00
- 52-week low
- HK$0.60
- Avg volume (3M)
- —
- Shares outstanding
- 144.71M
- Employees
- 450
- Next earnings
- —
About Biosino Bio-Technology and Science Incorporation
Biosino Bio-Technology & Science, Inc. engages in the manufacture, sale, and distribution of in-vitro diagnostic reagents and pharmaceutical products. It distributes a variety of mono and double diagnostic reagent products which are used by various medical institutions, independent laboratories, government public health testing centers, and individuals. The company was founded in 1988 and is headquartered in Beijing, China.
- ISIN
- CNE100000288
- Founded
- 1988
- Listed since
- Feb 27, 2006
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.